Requisite Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Requisite Capital Management's AMGN Position: Q1 2026 in Review
Requisite Capital Management reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $3.92K and leaving 920 shares worth $324K. The position accounts for 0.06% of the portfolio, ranked #76.
Requisite Capital Management first reported a position in AMGN in Q3 2023 and has held it in 10 quarters since. The position peaked at $397K in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Requisite Capital Management held 920 shares of Amgen worth $324K as of Q1 2026.
- Requisite Capital Management sold 11 Amgen shares in Q1 2026, an estimated $3.92K.
- Amgen made up 0.06% of Requisite Capital Management's portfolio in Q1 2026, its #76 holding.
- Requisite Capital Management first reported a position in Amgen in Q3 2023 and has held it in 10 quarters since.
- Requisite Capital Management's Amgen position peaked at $397K in Q3 2024.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Requisite Capital Management's 13F filing for Q1 2026, filed 14 May 2026.